We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 24.6%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+24.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$144M
AUM Growth
Cap. Flow
+$135M
Cap. Flow %
93.85%
Top 10 Hldgs %
8.25%
Holding
1,984
New
1,981
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 12.73%
2 Industrials 12.71%
3 Financials 12.24%
4 Technology 11.29%
5 Consumer Discretionary 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSTK icon
301
Shutterstock
SSTK
$200M
$103K 0.07%
+2,800
New +$90.6K
ZIXI
302
DELISTED
Zix Corporation
ZIXI
$103K 0.07%
+26,096
New +$109K
ANDV
303
DELISTED
Andeavor
ANDV
$103K 0.07%
+1,200
New +$103K
SCLN
304
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$103K 0.07%
+9,360
New +$83.2K
FC icon
305
Franklin Covey
FC
$235M
$102K 0.07%
+5,813
New +$99.3K
VNDA icon
306
Vanda Pharmaceuticals
VNDA
$298M
$102K 0.07%
+12,200
New +$100K
PHIIK
307
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$102K 0.07%
+5,400
New +$95K
JBSS icon
308
John B. Sanfilippo & Son
JBSS
$978M
$101K 0.07%
+1,464
New +$91.4K
SMMF
309
DELISTED
Summit Financial Group, Inc.
SMMF
$101K 0.07%
+6,515
New +$84.6K
BCR
310
DELISTED
CR Bard Inc.
BCR
$101K 0.07%
+500
New +$94.4K
HOPE icon
311
Hope Bancorp
HOPE
$1.82B
$100K 0.07%
+6,600
New +$98.8K
PENN icon
312
PENN Entertainment
PENN
$2.57B
$100K 0.07%
+6,000
New +$86K
TARO
313
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$100K 0.07%
+700
New +$99.4K
LHCG
314
DELISTED
LHC Group LLC
LHCG
$100K 0.07%
+2,800
New +$103K
CCK icon
315
Crown Holdings
CCK
$13.1B
$99K 0.07%
+2,000
New +$93.9K
JNJ icon
316
Johnson & Johnson
JNJ
$626B
$99K 0.07%
+915
New +$94.7K
PVH icon
317
PVH
PVH
$3.91B
$99K 0.07%
+1,000
New +$78.7K
UTMD icon
318
Utah Medical Products
UTMD
$229M
$99K 0.07%
+1,576
New +$92.9K
DF
319
DELISTED
Dean Foods Company
DF
$99K 0.07%
+5,688
New +$108K
BRKR icon
320
Bruker
BRKR
$8.69B
$98K 0.07%
+3,500
New +$87.3K
LSAK icon
321
Lesaka Technologies
LSAK
$414M
$98K 0.07%
+10,699
New +$108K
MMLP icon
322
Martin Midstream Partners
MMLP
$92.3M
$98K 0.07%
+4,896
New +$84.8K
PFE icon
323
Pfizer
PFE
$152B
$98K 0.07%
+3,478
New +$99.3K
SSB icon
324
SouthState Bank Corp
SSB
$10.7B
$98K 0.07%
+1,526
New +$98.2K
TILE icon
325
Interface
TILE
$2.24B
$98K 0.07%
+5,300
New +$89K

Similar funds

Acrospire Investment Management's Q1 2016 Portfolio in Review

Q1 2016 is the first quarter with a 13F filing on record for Acrospire Investment Management, which disclosed 1,984 positions worth $144M. Its ten largest holdings account for 8.2% of the portfolio.

Its largest position is State Street SPDR S&P 500 ETF Trust: 37,614 shares worth $7.73M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Industrials and Financials.

  • Acrospire Investment Management's largest Q1 2016 buy was State Street SPDR S&P 500 ETF Trust: 37,614 shares worth $7.73M.
  • Acrospire Investment Management's ten largest holdings make up 8.2% of its $144M portfolio in Q1 2016.
  • Acrospire Investment Management disclosed 1,984 positions in Q1 2016, its first 13F filing on record.

Based on Acrospire Investment Management's 13F filing for Q1 2016, filed 10 May 2016.